Defence Therapeutics Inc. (DTCFF)
USD 0.62
(3.69%)
USD 0.62
(3.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -13.19 Million CAD | -95.08% |
| 2023 | -6.76 Million CAD | 7.91% |
| 2022 | -7.34 Million CAD | -156.85% |
| 2021 | -2.85 Million CAD | -324.74% |
| 2020 | -673.18 Thousand CAD | -34493.11% |
| 2019 | -1946.00 CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -2.19 Million CAD | -27.09% |
| 2024 Q2 | -8.31 Million CAD | -278.67% |
| 2024 Q3 | -1.32 Million CAD | 84.04% |
| 2024 Q4 | -1.34 Million CAD | -1.54% |
| 2023 Q4 | -1.72 Million CAD | -28.71% |
| 2023 Q3 | -1.34 Million CAD | 32.44% |
| 2023 Q2 | -1.98 Million CAD | -16.75% |
| 2023 FY | -6.76 Million CAD | 7.91% |
| 2023 Q1 | -1.7 Million CAD | 21.83% |
| 2022 Q1 | -1.52 Million CAD | 9.19% |
| 2022 Q3 | -1.69 Million CAD | 12.7% |
| 2022 Q4 | -2.17 Million CAD | -28.54% |
| 2022 FY | -7.34 Million CAD | -156.85% |
| 2022 Q2 | -1.94 Million CAD | -26.87% |
| 2021 Q3 | -690.74 Thousand CAD | -56.19% |
| 2021 FY | -2.85 Million CAD | -324.74% |
| 2021 Q1 | -41.5 Thousand CAD | 91.2% |
| 2021 Q4 | -1.68 Million CAD | -143.9% |
| 2021 Q2 | -442.25 Thousand CAD | -965.55% |
| 2020 Q3 | -192.27 Thousand CAD | -6601.64% |
| 2020 Q1 | -6536.00 CAD | 0.0% |
| 2020 Q2 | -2869.00 CAD | 56.1% |
| 2020 FY | -673.18 Thousand CAD | -34493.11% |
| 2020 Q4 | -471.5 Thousand CAD | -145.23% |
| 2019 FY | -1946.00 CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bioxytran, Inc. | -4.28 Million USD | -208.249% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 82.401% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -4725.512% |
| SQZ Biotechnologies Company | -79.46 Million USD | 83.397% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -356.129% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 124.902% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 120.256% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -624.682% |
| Marizyme, Inc. | -65.34 Million USD | 79.811% |
| Genus plc | 7.9 Million USD | 267.001% |
| Pharming Group N.V. | -10.54 Million USD | -25.076% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -508.027% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -255.585% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -49.175% |
| ContraFect Corporation | -65.15 Million USD | 79.751% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -663.727% |
| IMV Inc. | -36.48 Million USD | 63.84% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -63.692% |
| ONE Bio Corp. | 8.67 Million USD | 252.053% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 74.478% |
| Mesoblast Limited | -87.95 Million USD | 85.0% |
| MultiCell Technologies, Inc. | -380.07 USD | -3471114.513% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -253.417% |
| Genscript Biotech Corporation | -95.47 Million USD | 86.182% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -1986.164% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -454.127% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -100.621% |
| Biomind Labs Inc. | -1.21 Million USD | -986.456% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -325.34% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -66.935% |
| Skye Bioscience, Inc. | -37.64 Million USD | 64.954% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -576.827% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -21.129% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -87994.585% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -170.014% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -88.935% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 16.876% |
| Accustem Sciences Inc. | -3.74 Million USD | -252.151% |
| EV Biologics, Inc. | -1.26 Million USD | -941.172% |
| Q BioMed Inc. | -2.05 Million USD | -542.907% |
| GB Sciences, Inc. | -1.36 Million USD | -868.882% |
| Alpha Cognition Inc. | -13.77 Million USD | 4.208% |
| CSL Limited | 2.64 Billion USD | 100.499% |
| Agentix Corp. | -1.37 Million USD | -860.045% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 77.91% |
| Enzolytics Inc. | -2.17 Million USD | -506.066% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -3.61 Million USD | -265.458% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -315.996% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -126.792% |
| argenx SE | -295.05 Million USD | 95.529% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 78.925% |
| HST Global, Inc. | -146.21 Thousand USD | -8923.353% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 13562.291% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -651.839% |
| Halberd Corporation | -79.67 Thousand USD | -16458.368% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 290.524% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -335.97% |
| Zenith Capital Corp. | -10.59 Million USD | -24.51% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -232.068% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -218.216% |
| AVAX Technologies, Inc. | -6.41 Million USD | -105.703% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -21728.114% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -557.969% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -56663.811% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -4.76 Million USD | -176.631% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1149.274% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -245.458% |
| Kadimastem Ltd | -3.3 Million USD | -298.895% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -8.48 Million USD | -55.524% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -2889.119% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -887.924% |
| LadRx Corporation | 400.44 Thousand USD | 3394.612% |
| Cell Source, Inc. | -5.32 Million USD | -147.933% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3075.382% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1389.003% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1389.003% |
| Affymax, Inc. | -14.42 Million USD | 8.534% |
| Mobile Lads Corp. | -2.26 Million USD | -482.914% |
| Itoco Inc. | -1.86 Million USD | -605.89% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -196.971% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -690.476% |
| International Stem Cell Corporation | -131 Thousand USD | -9971.027% |
| CytoDyn Inc. | -49.84 Million USD | 73.53% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -16593.084% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -5683.202% |
| Qrons Inc. | -789.34 Thousand USD | -1571.387% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1301.236% |
| SYBLEU INC | -180.3 Thousand USD | -7217.112% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | -531.947% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1193.436% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -718.053% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -24209.119% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -421.413% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 72.556% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -524.08% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1589.495% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -316.447% |
| Neutra Corp. | -233.46 Thousand USD | -5550.973% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 34.981% |
| PureTech Health plc | -65.69 Million USD | 79.918% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 37.963% |
| IXICO plc | -1.17 Million USD | -1019.953% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -32.901% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 76.906% |
| CSL Limited | 2.64 Billion USD | 100.499% |
| Cellectis S.A. | -103.17 Million USD | 87.213% |